Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Comparing Options in the Treatment of Patients With RVO

Robert L. Avery, MD, and Allen C. Ho, MD, get together with Michael S. Ip, MD, for a comprehensive overview of the Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) trial’s primary results and newer 6- to 12-month results. Dr. Ip answers the question of whether drug choice matters, examines the role of first- and second-line therapy, and explains how the study findings apply in the real world.


3 / 60 Series: Retina Today Journal Club


Show Citations

More Videos in this Series